$117M venture firm takes flight in Europe

A group of Elan veterans in Ireland have launched a €75 million ($117 million) venture fund for life sciences companies. Fountain Healthcare Partners, based in Dublin, plans to sink anywhere from €500,000 to €7 million in a variety of companies in Europe, with a big focus on Ireland. And the principals expect considerable demand for the cash.

"For companies looking to raise $10 to $15 million to undertake a phase I or phase II study, they really don't have dedicated venture capital funds to raise that money," says partner Aidan King.

- see this release
- read the report in the Wall Street Journal

Suggested Articles

Bluebird Bio offered the first glimpse of how its CAR-T follow-up is working in multiple myeloma patients who have tried several other treatments.

Zentalis is coming out of stealth with an $85 million series C, which will propel its lead programs into pivotal trials and broaden its pipeline.

The planned takeover centers on ARQ 531, a BTK inhibitor that triggered durable responses in patients with B-cell malignancies.